Béla Kádár

Béla Kádár

Auto-generated profile, based on publicly available information

Béla Kádár

Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2016 in Clinical Microbiology and Infection
Verified
Journal Article
Closed access
BSBalint Gergely Szabo
Balint Gergely Szabo
BKB. Kadar
B. Kadar
KLK. Szidonia Lenart
K. Szidonia Lenart
BDB. Dezsenyi
B. Dezsenyi
PKP. Kunovszki
P. Kunovszki
GPG. Prinz
G. Prinz

1 August 2013 in Current Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
BKB. Kadar
B. Kadar
BKB. Kocsis
B. Kocsis
KNK. Nagy
K. Nagy
DSDora Szabo
Dora Szabo
Polymyxins are polypeptide antibiotics, with a primary effect of membrane damaging due to their selective binding to the lipopolysaccharide of Gram-negative bacteria. Their nephro- and neurotoxic side effects limited their use, however, in the last decade the emergence of multidrug-resistant Gram-negative bacteria led to the reintroduction of polymyxins into clinical practice. This review provides an overview about the history and the latest developments of polymyxins. We describe the antimicrobial effects, pharmacodynamics, pharmacokinetics and different routes of administration. We highlight natural classic polymyxins, namely polymyxin B and E, the non-classic agents polymyxin M, S and T. Novel polymyxin chemical structure derivatives will be listed including NAB739, NAB740, NAB741 and NAB7061, that can have important therapeutical role in the future.

1 September 2010 in Acta Microbiologica Et Immunologica Hungarica
Verified
Journal Article
Closed access
BKB. Kádár
B. Kádár
MSM. Szász
M. Szász
KKKatalin Kristóf
Katalin Kristóf
NPNatasa Pesti
Natasa Pesti
GKG. Krizsán
G. Krizsán
DSDóra Szabó
Dóra Szabó
The aim of the study was to investigate the biofilm-production of 60 Pseudomonas aeruginosa strains isolated from clinical samples and to examine the effect of different antimicrobials and their combinations with clarithromycin on biofilm-formation. The minimal inhibitory concentrations (MICs), minimal biofilm inhibitory concentrations (MBICs), and antibiotic synergy by calculating the fractional inhibitory concentration (FIC) index were determined for the following antibiotics: ceftazidime, cefepime, piperacillin/tazobactam, imipenem, meropenem, levofloxacin, ciprofloxacin, gentamicin, amikacin, tobramycin, netilmicin and clarithromycin. A total of 14 (23.3%) isolates out of 60 isolates of P. aeruginosa were biofilm positive. Cefepime, imipenem and meropenem had the lowest MIC 90 values. Piperacillin/tazobactam and clarithromycin had the highest MIC 90 values. Imipenem, meropenem, piperacillin/tazobactam and clarithromycin had the lowest MBIC 90 values. For biofilm-forming P. aeruginosa strains 2-fold to 128-fold higher MBIC values than MIC values were obtained for ceftazidime, cefepime, imipenem, amikacin and netilmicin. The MBIC was 2-fold to 512-fold lower then the MIC values in the case of piperacillin/tazobactam, ciprofloxacin, levofloxacin and clarithromycin. Synergy was generally demonstrated for clarithromycin in combination with aminoglycosides, fluoroquinolones or ceftazidime. However, surprisingly it was found that combinations of clarithromycin with carbapenems or cefepime led to an antagonistic interaction: combination of clarithromycin with imipenem, meropenem or ertapenem showed antagonism in 37.5%, 50% and 62.5% of the strains tested whereas its combination with cefepime expressed antagonism in 75% of the strains, respectively. To the best of our knowledge no one has previously described this phenomenon so far.

1 December 2015 in Acta Microbiologica Et Immunologica Hungarica
Verified
Journal Article
Closed access
BKBéla Kádár
Béla Kádár
BKBéla Kocsis
Béla Kocsis
KKKatalin Kristof
Katalin Kristof
ÁTÁkos Tóth
Ákos Tóth
DSDóra Szabó
Dóra Szabó
In this study susceptibility to different antimicrobial peptides was investigated on colistin-susceptible and colistin-resistant identical pulsotype strains of KPC-2 producing Klebsiella pneumoniae ST258 as well as colistin-susceptible and colistin-resistant Enterobacter asburiae strains isolated from clinical samples. In our test, bacteria were exposed to 50 mg/ml lactoferrin, lysozyme and protamine — cationic antimicrobial peptides belonging to innate immune system and having structural similarity to polymyxins — in separate reactions. After 18 hours incubation of colonies were counted. 40% of colistin-resistant K. pneumoniae strains and 97% of colistin-susceptible counterpart strains were lysed by protamine whereas 87% and 100% colony forming unit decrease by lysozyme was seen, respectively. In the case of colistin-resistant E. asburiae strains 1 log10 cell count increase were observed after treatment with lysozyme and 1.56 log10 after lactoferrin exposure compared to the initial number whereas the colistin-susceptible showed no relevant cell count increase. Our findings suggest that acquired colistin-resistance in Enterobacteriaceae is associated with tolerance against antimicrobial peptides.

1 October 2017 in Journal of Microbiology, Immunology and Infection
Verified
Journal Article
Open access
BKBela Kocsis
Bela Kocsis
BKBéla Kádár
Béla Kádár
ÁTÁkos Tóth
Ákos Tóth
AFAlexandra Fullár
Alexandra Fullár
DSDora Szabo
Dora Szabo
Resistance determinants of a colistin susceptible and five colistin resistant Klebsiella pneumoniae ST258 from a Hungarian outbreak were investigated. A novel MgrB variant in colistin susceptible strain was found. Elevated phoP and arn gene expressions and wild-type PmrB in all colistin resistant K. pneumoniae were detected. All strains lacked mcr-1

1 February 2021 in Diagnostic Microbiology and Infectious Disease
Verified
Journal Article
Closed access
BSBalint Gergely Szabo
Balint Gergely Szabo
LDLilla Duma
Lilla Duma
KLKatalin Szidonia Lenart
Katalin Szidonia Lenart
RKRebeka Kiss
Rebeka Kiss
EVEszter Vad
Eszter Vad
BKBela Kadar
Bela Kadar